Bibliografia
Alford F. P., Bellair J. T., Burger H. G., Lovett N.: A Simplified Assay for Somatomedin — J. Endocr.54, 365, 1972.
Almqvist S.: Studies on Sulfation Factor (SF) Activity of Human Serum. Effect of Human Growth Hormone on SF Levels in Pituitary Dwarfism — Acta endocr. (Kbh.)35, 381, 1960.
Almqvist S.: Studies of Sulfation Factor (SF) Activity of Human Serum. Evaluation of an Improved Method for the in Vitro Bioassay of SF and the Effect of Glutamine and Human Growth Hormone in the System — Acta endocr. (Kbh.)36, 31, 1961.
Almqvist S., Falkheden T.: Studies on Sulfation Factor (SF) Activity of Human Serum. Rate of Decrease of Serum SF after Hypophysectomy — Acta endocr. (Kbh.)37, 315, 1961.
Almqvist S., Rune I.: Studies on Sulfation Factor (SF) Activity of Human Serum. The Variation of SF with Age — Acta endocr. (Kbh.)36, 566, 1961.
Baumann G., Cain J. P., Dingmann J. F.: Gigantism with Hypopituitarism — Amer. med. J.53, 805, 1972.
Beck J. C., Gonda A., Hamid M. A., Morgan R. D., Rubinstein D., McGarry R. E.: Some Metabolic Changes Induced by Primate Growth Hormone and Purified Ovine Prolactin — Metabolism13, 1108, 1964.
Bonati B., Della Casa R., Marrama P., Ventura E.: Somatotropo ed epatopatie croniche — Atti 13° Congr. Soc. Ital. Endocr. Roma 1970. Edizioni Medico-Scientifiche, Torino, 1970; p. 79.
Bostrom H., Jorpes E., Mansson B., Roden L., Vestermark A.: On the Partial Purification of a Liver Factor Stimulating the Sulphate Exchange of Chondroitinsulphuric Acid — Ark. Kem.8, 469, 1955.
Brasel J. A., Wright J. C., Wilkins L., Blizzard R. M.: An Evaluation of Seventy-Five Patients with Hypopituitarism Beginning in Childhood — Amer. J. Med.38, 484, 1965.
Bürgi H., Müller W. A., Humbel R. E., Froesch E. R.: Purification of Plasma Protein with Non-Suppressible Insulin-Like Activity — Diabetologia1, 77, 1965.
Bürgi H., Müller W. A., Humbel R. E., Labhart A., Froesch E. R.: Non-Suppressible Insulin-Like Activity of Human Serum. I. Physicochemical Properties, Extraction and Partial Purification — Biochim. biophys. Acta (Amst.)121, 349, 1966.
Buxtorf U.: Non-Suppressible Insulin-Like Activity of Human Serum. IV. Effects of Purified Non-Suppressible Insulin-Like Activity and of Insulin on Protein Synthesis of Adipose Tissue from (14C)-Glucose, (14C)-Pyruvate and (14C)-Glycine — Biochim. biophys. Acta (Amst.)177, 512, 1969.
Cohen S.: Isolation of a Mouse Submaxillary Gland Protein Accelerating Incisor Eruption and Eyelid Opening in the Newborn Animal — J. biol. Chem.237, 1555, 1962.
Cuatrecasas P.: Interaction of Insulin with the Cell Membrane: the Primary Action of Insulin — Proc. nat. Acad. Sci. (Wash.)63, 450, 1969.
Cuatrecasas P.: Insulin-Receptor Interactions in Adipose Tissue Cells: Direct Measurement and Properties — Proc. nat. Acad. Sci. (Wash.)68, 1264, 1971.
Daughaday W. H.: Sulfation Factor Regulation of Skeletal Growth. A Stable Mechanism Dependent on Intermittent Growth Hormone Secretion — Amer. J. Med.50, 277, 1971.
Daughaday W. H.: The Sulfation Factor: Hypothesis: Recent Observations — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 168.
Daughaday W. H.: Regulation of Skeletal Growth by Sulfation Factor — Advanc. intern. Med.17, 237, 1971.
Daughaday W. H., Garland J. T.: citato inGourmelen e Coll.48.
Daughaday W. H., Hall K., Raben M. S., Salmon W. D. Jr., van den Brande J. L., van Wyk J. J.: Somatomedin: a Proposed Designation for the ‘Sulphation Factor’ — Nature (Lond.)235, 107, 1972.
Daughaday W. H., Heinz J. N., Srivastava L., Hammer C.: Sulfation Factor: Studies of its Removal from Plasma and Metabolic Fate in Cartilage — J. Lab. clin. Med.72, 803, 1968.
Daughaday W. H., Mariz J. K.: Conversion of Proline-U-C14 to Labeled Hydroxyproline by Rat Cartilage in Vitro: Effects of Hypophysectomy, Growth Hormone, and Cortisol — J. Lab. clin. Med.59, 741, 1972.
Daughaday W. H., Reeder C.: Synchronous Activation of DNA Synthesis in Hypophysectomized Rat Cartilage by Growth Hormone — J. Lab. clin. Med.68, 357, 1966.
Daughaday W. H., Salmon W. D. Jr., Alexander F.: The Measurement of Serum Sulfation Factor as an Index of Somatotropin Activity in Man — J. clin. Invest.37, 888, 1958.
Daughaday W. H., Salmon W. D. Jr., Alexander F.: Sulfation Factor Activity of Sera from Patients with Pituitary Disorders — J. clin. Endocr.19, 743, 1959.
Ellis S., Huble J., Simpson M. E.: Influence of Hypophysectomy and Growth Hormone on Cartilage Sulfate Metabolism — Proc. Soc. exp. Biol. (N. Y.)84, 603, 1953.
Finkelstein J. W., Kream J., Ludan A., Hellman L.: Sulfation Factor (Somatomedin): an Explanation for Continued Growth in the Absence of Immunoassayable Growth Hormone in Patients with Hypothalamic Tumors — J. clin. Endocr.35, 13, 1972.
Finkelstein J. W., Roffwarg H. D., Boyar R. M., Kream J., Hellman L.: Age Related Change in 24 Hour Secretion of Growth Hormone — J. clin. Endocr.35, 665, 1972.
Franchimont P.: Sécrétion normale et pathologique de la somatotrophine et des gonadotrophines humaines — Masson et Cie Éd., Paris, 1971.
Fraster S. D., Smith F. G. Jr.: Return of Normal Growth Following Removal of a Craniopharyngioma — Amer. J. Dis. Child.116, 311, 1968.
Frazier W. A., Angeletti R. H., Bradshaw R. A.: Nerve Growth Factor and Insulin. Structural Similarities Indicate an Evolutionary Relationship Reflected by Physiological Action — Science176, 482, 1972.
Froesch E. R., Bürgi H., Müller W. A., Humbel R. E., Jakob A., Labhart A.: Nonsuppressible Insulin-Like Activity of Human Serum: Purification, Physiochemical and Biological Properties and its Relation to Total Serum ILA — Recent. Progr. Hormone Res.23, 565, 1967.
Froesch E. R., Bürgi H., Ramseir E. B., Bally P., Labhart A.: Antibody-Suppressible and Nonsuppressible Insulin-Like Activities in Human Serum and Their Physiologic Significance. An Insulin Assay with Adipose Tissue of Increased Precision and Specificity — J. clin. Invest.42, 1816, 1963.
Froesch E. R., Morel B., Zapf J., Zingg A. E., Meuli C., Schlumpf U., Heimann R., Eigenmann E., Humbel R. E.: NSILA-S: Insulin-Like Properties, Receptor Binding Activities and Relationship to Somatomedin — Acta endocr. (Kbh.)184 (Suppl.), 183, 1974.
Froesch E. R., Müller W. A., Bürgi H., Waldvogel M., Labhart A.: Nonsuppressible Insulin-Like Activity of Human Serum. II. Biological Properties of Plasma Extracts with Nonsuppressible Insulin-Like Activity — Biochim. biophys. Acta (Amst.)121, 360, 1966.
Garland J. T., Daughaday W. H.: Feedback Inhibition of Pituitary Growth Hormone in Rats Infested with Spirometra Mansonoides — Proc. Soc. exp. Biol. (N. Y.)139, 497, 1972.
Garland J. T., Lottes M. E., Kozak S., Daughaday W. H.: Stimulation of DNA Synthesis in Isolated Chondrocytes by Sulfation Factor — Endocrinology90, 1086, 1972.
Garland J. T., Ruegamer W. R., Daughaday W. H.: Induction of Sulfation Factor Activity by Infection of Hypophysectomized Rats with Spirometra Mansonoides — Endocrinology88, 924, 1971.
Geiger W.: The Way of HCG, HCS and STH into the Amniotic Fluid: Conclusions by their Dynamic Equilibrance and Renal Excretion — Acta endocr. (Kbh.)73 (Suppl. 177), 238, 1973.
Giordano G., Foppiani E., Minuto F., Marugo M., Comaschi M.: Obesità ed ormone somatotropo. II. Il comportamento della somatomedina in corso di obesità — Folia endocr. (Roma)27, 369, 1974.
Giordano G., Foppiani E., Minuto F., Perroni D.: Comportamento dell’ormone somatotropo e della somatomedina nei neonati — Congr. Endocr. Pediat., Genova 1974.
Giordano G., Foppiani E., Minuto F., Perroni D.: Comportamento della somatomedina nei soggetti cirrotici — Boll. Soc. ital. Biol. sper. (in stampa).
Giordano G., Marugo M., Minuto F., Barreca T.: Comportamento della secrezione dell’ormone somatotropo in corso di epatopatie croniche — Arch. E. Maragliano Pat. Clin.27, 175, 1971.
Giordano G., Marugo M., Minuto F., Barreca T.: Significato della somatotropinemia basale nell’uomo in condizioni normali e patologiche — Arch. E. Maragliano Pat. Clin.28, 73, 1972.
Giordano G., Minuto F., Foppiani E., Comaschi A.: Il dosaggio della somatomedina in soggetti normali e patologici Atti Giornate Endocrinologiche Pisane, Pisa 1973. Pacini Ed., Pisa, 1974; p. 324.
Giordano G., Minuto F., Foppiani E., Perroni D.: Il test dell’induzione somatomedinica con HGH nella diagnostica delle iposomie — Symp. Int. su «Il trattamento dei ritardi staturali», Fiuggi 1974.
Gourmelen M., Mimouni M., Bastide M. H., Binoux M., Lestradet H.: Reprise Spontanée de la croissance au cours d’une insuffisance hypothalamo-hypophysaire — Ann. Pédiat.20, 646, 1973.
Grant D. B., Hambley J., Becker D., Pimstone B. L.: Reduced Sulfation Factor in Undernourished Children — Arch. Dis. Childh.48, 596, 1973.
Grant D. B., Kaplan S. L., Grumbach M. M.: Studies on the Cross-Reaction between Human Growth Hormone and Human Chorionic Somatomammotropin in Radioimmunoassay Systems — J. clin. Endocr.32, 88, 1971.
Greenspan F. S., Li C. H., Simpson M. E., Evans H. M.: Bioassay of Hypophyseal Growth Hormone: the Tibia Test — Endocrinology45, 455, 1949.
Hall K.: Quantitative Determination of the Sulphation Factor Activity in Human Serum — Acta endocr. (Kbh.)63, 338, 1970.
Hall K.: Effect of Intravenous Administration of Human Growth Hormone on Sulphation Factor Activity in Serum of Hypopituitary Subjects — Acta endocr. (Kbh.)66, 491, 1971.
Hall K.: Human Somatomedin: Determination, Occurence, Biologic Activity and Purification — Acta endocr. (Kbh.)163 (Suppl.), 1972.
Hall K., Holmgren A., Lindahl U.: Purification of a Sulphation Factor from Skeletal Muscle of Rat — Biochim. biophys. Acta (Amst.)201, 398, 1970.
Hall K., Olin P.: Sulphation Factor Activity and Growth Rate during Long-Term Treatment of Patients with Pituitary Dwarfism with Human Growth Hormone — Acta endocr. (Kbh.)69, 417, 1972.
Hall K., Uthne K.: Human Growth Hormone and Sulfation Factor — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 192.
Hall K., Uthne K.: Some Biological Properties of Purified Sulfation Factors (SF) from Human Plasma — Acta med. scand.190, 137, 1971.
Hall K., van Wyk J. J.: Somatomedin — In:Martini L., James V. H. T. (Eds): Current Topics in Experimental Endocrinology. Academic Press, New York, 1974; p. 190.
Heinz J. N., Garland J. T., Daughaday W. H.: Incorporation of35S Sulfate into Rat Cartilage Explants in Vitro. Effects of Aging on Responsiveness to Stimulation by Sulfation Factor — Endocrinology87, 688, 1970.
Hintz R. L., Clemmons D. R., Underwood L. E., van Wyk J. J.: Competitive Binding of Somatomedin to the Insulin Receptor of Adipocytes, Condrocytes, and Liver Membranes — Proc. nat. Acad. Sci. (Wash.)69, 2351, 1972.
Holmes L. B., Frantz A. G., Rabkin M. T., Stuart-Soeldner J., Crawford J. D.: Normal Growth with Subnormal Growth-Hormone Levels — New Engl. J. Med.279, 559, 1968.
Jakob A., Hauri Ch., Froesch E. R.: Nonsuppressible Insulin-Like Activity in Human Serum. III. Differentiation of Two Distinct Molecules with Nonsuppressible ILA — J. clin. Invest.47, 2678, 1968.
Job J. C., Lambertz J., Sizonenko P., Rossier A.: La croissance des enfants atteints de craniopharyngiome. Vitesse de croissance et résultats des dosages d’hormone de croissance dans le plasma avant et après intervention chirurgicale — Arch. franç. Pédiat.27, 341, 1970.
Kaplan S. L., Grumbach M. M.: Studies on Human and Simian Placental Hormone with Growth Hormone-Like and Prolactin-Like Activities — J. clin. Endocr.24, 80, 1964.
Kenny F. M., Guyda H. J., Wright J. C., Friesen H. G.: Prolactin and Somatomedin in Hypopituitary Patients with ‘Catch-up’ Growth Following Operations for Craniopharyngioma — J. clin. Endocr.36, 378, 1973.
Kenny F. M., Iturzaeta N. F., Mintz D., Brash A., Garces L., Susen A., Askari N. A.: Iatrogenic Hypopituitarism in Craniopharyngioma: Unexplained ‘Catch-up’ Growth in Three Children — J. Pediat.72, 766, 1968.
Killifer F. A., Stein W. E.: Clinic Effect of Hypothalamic Injury — Arch. Neurol. (Chic.)22, 419, 1970.
Kostyo J. L., Nutting D. F.: Acute in Vivo Effects of GH on Protein Synthesis in Various Tissues of Hypophysectomized Rats and their Relationship to the Levels of Thymidine Factor and Insulin in the Plasma — Hormone metab. Res.5, 167, 1973.
Kostyo J. L., Uthne K., Reagan C. R., Gimpel L. P.: Comparison of the Effects of Growth Hormone and Somatomedin on Skeletal Muscle Metabolism — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1973; p. 127.
Laron Z., Pertzelan A., Karp M., Kowadlo-Silberfeld A., Daughaday W. H.: Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses — J. clin. Endocr.33, 332, 1971.
Laron Z., Pertzelan A., Mannheimer S.: Genetic Pituitary Dwarfism with High Serum Concentration of HGH. A New Inborn Error of Metabolism — Israel J. Med. Sci.2, 152, 1966.
Lyngsøe J.: Seruminsulin. A Review — Acta med. scand.279 (Suppl. 441), 1, 1965.
Marshall R. N., Underwood L. E., Voina S. J., Foushee D. B., van Wyk J. J.: Characterization of the Insulin- and Somatomedin-C Receptors in Human Placental Cell Membranes — J. clin. Endocr.39, 283, 1974.
Matson D. D., Crigler J. F. Jr.: Management of a Craniopharyngioma in Childhood — J. Neurosurg.30, 377, 1969.
McConaghey P.: The Production of ‘Sulphation Factor’ by Rat Liver — J. Endocr.52, 1, 1972.
McConaghey P., Muller J.: Sulfation Factor: its Production by the Rat Liver and Kidney — 2nd Int. Symp. on Growth Hormone, Milano 1971. Excerpta Medica Foundation, Amsterdam, 1971; abstract # 46.
McConaghey P., Sledge C. B.: Production of ‘Sulphation Factor’ by the Perfused Liver — Nature (Lond.)225, 1249, 1970.
Meade R. C., Klitgaard H.M., Holanders E.: Characteristics of Nonsuppressible Insulin-Like Activity in Fasting Human Serum — Diabetes21, 271, 1972.
Mueller J. F., Reed P.: Growth Stimulation Induced by Infection with Spirometra Mansonoides Spargana in Propylthiouracil-Treated Rats — J. Parassit.54, 51, 1968.
Oelz O., Jakob A., Diem S., Froesch F. R.: Non-Suppressible Insulin-Like Activity in Human Serum. VI. Difference between the Action of Insulin and That of Precipitated Non-Suppressible Insulin-Like Activity on Glycogen Synthesis of Rat Adipose Tissue and Muscle — Biochim. biophys. Acta (Amst.)230, 20, 1971.
Pierson R. W. Jr., Temin H. M.: The Partial Purification from Calf Serum of a Fraction with Multiplication-Stimulating Activity for Chicken Fibroblasts in Cell Culture with Non-Suppressible Insulin-Like Activity — J. cell. Physiol.79, 319, 1972.
Phillips L. S., Herington A. C., Daughaday W. H.: Hormone Effects on Somatomedin Action and Somatomedin Generation — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 50.
Phillips L. S., Herington A. C., Müller M. C., Daughaday W. H.: Cortisol Inhibition of Growth Hormone-Induced Somatomedin (Sulfation Factor) Generation — Clin. Res.21, 68, 1973.
Poffenbarger P. L., Espinosa de los Monteros Mena A., Steinke J.: Non-suppressible Insulin-Like Activity: Immunochemical and Physicochemical Evidence against its Pancreatic Origin — Metabolism19, 509, 1970.
Raben M. S.: Growth Hormone: Anabolic and Anticatabolic Agent — Diabetes14, 374, 1965.
Raben M. S., Murakawa S., Matute M.: Some Observations Concerning Serum ‘Thymidine Factor’ — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 124.
Randle P. J.: Enhancement of Insulin Action by Pituitary Growth Hormone — Nature (Lond.)174, 1053, 1954.
Randle P. J.: Plasma-Insulin Activity in Acromegaly Assayed by Rat-Diaphragm Method. Preliminary Comunication — Lancet1, 441, 1954.
Randle P. J., Young F. G.: The Influence of Pituitary Growth Hormone on Plasma Insulin Activity — J. Endocr.13, 335, 1956.
Rimoin D. L., Merimee T. J., Rabinowitz D., McKusick W. A.: Genetic Aspects of Clinical Endocrinology — Recent Progr. Hormone Res.24, 365, 1968.
Rosenberg D., David L., Bertrand J., Ruitton-Ullengo Laras C., Picot C., Monnet P.: Craniopharyngiome. Reptise de croissance après l’intervention malgré le deficit en hormone somatotrope — Arch. franç. Pédiat.27, 335, 1970.
Ruegamer W. R.: citato inDaughaday 17.
Ruegamer W. R., Muller J. F.: Proc. Amer. Thyroid Ass. 1969; abstract # 65.
Salmon W. D. Jr.: Investigation with a Partially Purified Preparation of Serum Sulfation Factor: Lack of Specificity for Cartilage Sulfation — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 180.
Salmon W. D. Jr.: Effects of Somatomedin on Cartilage Metabolism: Further Observations on an Inhibiting Serum Factor — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 76.
Salmon W. D. Jr., Daughaday W. H.: A Hormonally Controlled Serum Factor which Stimulates Sulfate Incorporation by Cartilage in Vitro — J. Lab. clin. Med.49, 825, 1957.
Salmon W. D. Jr., Duvall M. R.: A Serum Fraction with ‘Sulfation Factor Activity’ Stimulates in Vitro Incorporation of Leucine and Sulfate into Protein-Polysaccharide Complexes, Uridine into RNA and Thymidine into DNA of Costal Cartilage from Hypophysectomized Rats — Endocrinology86, 721, 1970.
Salmon W. D. Jr., Duvall M. R.: In Vitro Stimulation of Leucine Incorporation into Muscle and Cartilage Protein by a Serum Fraction with Sulfation Factor Activity: Differentiation of Effects from Those of Growth Hormone and Insulin — Endocrinology87, 1168, 1970.
Salmon W. D. Jr., Hosse B. R.: Stimulation of HeLa Cell Growth by a Serum Fraction with Sulfation Factor Activity — Proc. Soc. exp. Biol. (N. Y.)136, 805, 1971.
Schoeffling K., Ditschuneit H., Petzoldt R., Beyer J., Pfeiffer E. F., Sirek A., Geerling H., Sirek O. V.: Serum Insulin-Like Activity in Hypophysectomized and Pancreatectomized (Houssay) Dogs — Diabetes14, 658, 1965.
Snipes C. A.: Effects of Growth Hormone and Insulin on Aminoacid and Protein Metabolism — Quart. Rev. Biol.43, 127, 1968.
Steelman L. S., Glitzer M. S., Ostlind D. A., Mueller J. F.: Biological Properties of the Growth Hormone-Like Factor from the Pletocercoid of ‘Spirometra Mansonoides’ — Recent Progr. Hormone Res.22, 97, 1971.
Steelman L. S., Morgan E. R., Cuccaro A. J., Glitzer M. S.: Growth Hormone-Like Activity in Hypophysectomized Rats Implanted with Spirometra Mansonoides Spargana — Proc. Soc. exp. Biol. (N. Y.)133, 269, 1970.
Tanner J. M.: Human Growth Hormone — Nature (Lond.)237, 433, 1972.
Taylor J. M., Mitchell W. M., Cohen S.: Epidermal Growth Factor. Physical and Chemical Properties — J. biol. Chem.247, 5928, 1972.
Underwood L. E., Hintz R. L., Voina S. J., van Wyk J. J.: Human Somatomedin, the Growth Hormone Dependent Sulfation Factor, Is Anti-Lipolytic — J. clin. Endocr.35, 194, 1972.
Uthne K.: Human Somatomedins: Purification and Some Studies on Their Biological Actions — Acta endocr. (Kbh.)175 (Suppl.), 1973.
Uthne K., Hall K.: Somatomedin Purification and Biological Action in Vitro — Acta endocr. (Kbh.)177 (Suppl.), 202, 1973.
Uthne K., Kostyo J. C., Reagan C. R., Gimpel P. L.: Effect of Somatomedin (SF) on Transport and Incorporation of Sugar and Aminoacid in Rat Muscle — Acta endocr. (Khb.)177 (Suppl.), 203, 1973.
Uthne K., Westermark B., Wasteson A.: Purification on Somatomedin from Human Plasma Stimulating DNA Synthesis in Human Glia-Like Cells — J. cell. comp. Physiol. 1973 (in stampa).
van den Brande J. L., du Caju M. V. L.: Plasma Somatomedin Activity in Children with Growth Disturbances — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 98.
van den Brande J. L., du Caju M. V. L.: An Improved Technique for Measuring Somatomedin Activity in Vitro — Acta endocr. (Kbh.)75, 233, 1974.
van den Brande J. L., Kootte K., Tielenburg R., van der Wilk M., Huyser T.: Studies of Plasma Somatomedin Activity in Different Animal Species — Acta endocr. (Kbh.)75, 243, 1974.
van den Brande J. L., Kootte E. F., Tielenburg R., van der Wilk M., Koot T.: Plasma Sulfation Factor in Different Animal Species — 2nd Int. Symp. on Growth Hormone, Milano 1971. Excerpta Medica Foundation, Amsterdam, 1971; abstract # 47.
van den Brande J. L., van Wyk J. J., Weaver R. P., Mayberry H. E.: Partial Characterization of Sulphation and Thymidine Factors in Acromegalic Plasma — Acta endocr. (Kbh.)66, 65, 1971.
van Wyk J. J., Hall K., van den Brande J. L., Weaver R. P.: Further Purification and Characterization of Sulfation Factor and Thymidine Factor from Acromegalic Plasma — J. clin. Endocr.32, 389, 1971.
van Wyk J. J., Hall K., van den Brande J. L., Weaver R. P., Uthne K., Hintz R. L., Harrison J. H., Mathewson P.: Partial Purification from Human Plasma of a Small Peptide with Sulfation Factor and Thymidine Factor Activities — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 155.
van Wyk J. J., Hall K., Weaver R. P.: Partial Purification and Characterization of Sulphation and Thymidine Factor from Plasma — Biochim. biophys. Acta (Amst.)192, 560, 1969.
van Wyk J. J., Hintz R. L., Clemmons D. R., Hall K., Uthne K.: Human Somatomedin, the Growth Hormone Dependent Sulfation and Thymidine Factor — In:Scow R. (Ed.): Endocrinology. Excerpta Medica Foundation, Amsterdam, 1973; p. 642.
van Wyk J. J., Underwood L. E., Hintz R. L., Voina S. J., Weaver R. P.: Chemical Properties and Some Biological Effects of Human Somatomedin — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 15.
van Wyk J. J., Underwood L. E., Hintz R. L., Voina S. J., Weaver R. P.: The Somatomedin: a Family of Insulin-Like Hormones under Growth Hormone Control — Recent Progr. Hormone Res. 1974 (in stampa).
Varma S. K., Sönksen P. H., Varma K., Soeldner J. S., Selenkow H. A., Emerson K. J.: Measurement of Human Growth Hormone in Pregnancy and Correlation with Human Placental Lactogen — J. clin. Endocr.32, 328, 1971.
Wiedemann E., Schwartz E.: Suppression of Growth Hormone-Dependent Human Serum Sulfation Factor by Estrogen — J. clin. Endocr.34, 51, 1972.
Wright P. H.: Plasma-Insulin Activity in Acromegaly and Spontaneous Hypoglycaemia — Lancet1, 951, 1960.
Yde H.: A Simplified Technique for the Determination of Growth Hormone Dependent Sulfation Factor, Using Intact Animals — Acta endocr. (Kbh.)57, 557, 1968.
Zahnd G. R., Steinke J., Renold A. E.: Early Metabolic Effects of Human Growth Hormone — Proc. Soc. exp. Biol. (N. Y.)105, 455, 1960.
Zimmerman T. S., White M. G., Daughaday W. H., Goetz F. G.: Hypopituitarism with Normal or Increased Height. Report of Two Cases, with Measurements of Plasma Growth Hormone Levels — Amer. J. Med.42, 146, 1967.
Zingg A. E., Froesch E. R.: Effects of Partially Purified Preparations with Non-suppressible Insulin-Like Activity (NSILA-S) on Sulfate Incorporation into Rat and Chicken Cartilage — Diabetologia9, 472, 1973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giordano, G. Le somatomedine. Significato e prospettive. Acta diabet. lat 12 (Suppl 1), 48–73 (1975). https://doi.org/10.1007/BF02581144
Issue Date:
DOI: https://doi.org/10.1007/BF02581144